N-3 PUFA as an ergogenic supplement modulating muscle hypertrophy and strength: a systematic review
Autor: | Helios Pareja-Galeano, Carlos Romero-Morales, María Martinez-Ferran, Jaime López-Seoane |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
030309 nutrition & dietetics Physical exercise Inflammation Industrial and Manufacturing Engineering law.invention Muscle hypertrophy 03 medical and health sciences 0404 agricultural biotechnology Randomized controlled trial law Internal medicine Fatty Acids Omega-3 Delayed onset muscle soreness medicine Humans Muscle Skeletal chemistry.chemical_classification 0303 health sciences business.industry Skeletal muscle Myalgia Hypertrophy 04 agricultural and veterinary sciences General Medicine 040401 food science medicine.anatomical_structure chemistry Dietary Supplements Cardiology medicine.symptom Range of motion business Food Science Polyunsaturated fatty acid |
Zdroj: | Critical Reviews in Food Science and Nutrition. 62:9000-9020 |
ISSN: | 1549-7852 1040-8398 |
Popis: | There is growing evidence that suggests that n-3 polyunsaturated fatty acids (PUFA) may improve physical performance when combined with proper training through modulation of muscle hypertrophy, muscle strength, and delayed onset muscle soreness (DOMS). This systematic review aims to examine the effect and optimal dosage of n-3 PUFA supplementation on muscle hypertrophy, muscle strength, and DOMS when combined with physical exercise. The PubMed, Web of Science, MEDLINE Complete, CINAHL and SPORTDiscus databases were searched following the PRISMA guidelines. Randomized controlled trials performed with healthy humans were considered. Fifteen studies with a total of 461 individuals were included in this systematic review. All of them measured muscle function (short physical performance test, range of motion (ROM), electromechanical delay (EMD), muscle echo intensity or muscle quality) and DOMS. Fourteen studies evaluated muscle strength and only six assessed muscle hypertrophy. Our results demonstrated that n-3 PUFA does not improve muscle hypertrophy, muscle strength or skeletal muscle biomarkers of inflammation and muscle damage beyond the benefits obtained by the training itself. Nevertheless, n-3 PUFA improves DOMS recovery and muscle function (measured by ROM, EMD and muscle quality). |
Databáze: | OpenAIRE |
Externí odkaz: |